Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Pemetrexed disodium may stop the growth of cancer cells by blocking some of the
enzymes needed for cell growth. Studying samples of cerebrospinal fluid and blood from
patients with cancer in the laboratory may help doctors learn how pemetrexed disodium works
in the body and identify biomarkers related to cancer.
PURPOSE: This clinical trial is studying the side effects and how well pemetrexed disodium
works in treating patients with leptomeningeal metastases.